Centessa Pharmaceuticals (CNTA) Other Gross PP&E Adjustments (2022 - 2025)
Historic Other Gross PP&E Adjustments for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to -$9.7 million.
- Centessa Pharmaceuticals' Other Gross PP&E Adjustments rose 912.91% to -$9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.7 million, marking a year-over-year increase of 912.91%. This contributed to the annual value of -$11.3 million for FY2024, which is 195.91% up from last year.
- Centessa Pharmaceuticals' Other Gross PP&E Adjustments amounted to -$9.7 million in Q3 2025, which was up 912.91% from -$10.8 million recorded in Q2 2025.
- Centessa Pharmaceuticals' Other Gross PP&E Adjustments' 5-year high stood at -$1.3 million during Q2 2022, with a 5-year trough of -$13.9 million in Q1 2023.
- Moreover, its 4-year median value for Other Gross PP&E Adjustments was -$10.8 million (2025), whereas its average is -$9.0 million.
- As far as peak fluctuations go, Centessa Pharmaceuticals' Other Gross PP&E Adjustments tumbled by 88049.51% in 2023, and later soared by 1613.3% in 2024.
- Over the past 4 years, Centessa Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at -$2.8 million in 2022, then plummeted by 304.54% to -$11.5 million in 2023, then increased by 1.96% to -$11.3 million in 2024, then rose by 13.45% to -$9.7 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$9.7 million for Q3 2025, versus -$10.8 million for Q2 2025 and -$10.8 million for Q1 2025.